Medtech InsightIsrael has experienced serious societal disruption – with plans to overhaul the judiciary, COVID and notably the conflict in Gaza – but its ability to develop innovative healthtech has been fairly und
In VivoIsrael has experienced serious societal disruption – with plans to overhaul the judiciary, COVID and notably the conflict in Gaza – but its ability to develop innovative healthtech has been fairly und
In VivoBiopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso
Scrip“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office